To achieve our goal of better symptom management and improved quality of life for people with life-limiting illness or cancer diagnosis, we focus our research on eight symptom nodes:
- Appetite and cachexia
- Cognitive and neurological disorders
- Gut dysfunction
Each node is overseen by a group of dedicated clinicians and researchers who lead research and clinical trials that build our knowledge about the best medications and treatments for people affected by these symptoms.
Symptom node subcommittees (SNSC) are approved by the Trials Management Committee (TMC). SNSCs have oversight of all individual clinical research studies undertaken about the symptom. The SNSC and TMC form part of both the Palliative Care Clinical Studies Collaborative PaCCSC governance and Cancer Symptom Trials (CST) governance.
Terms of reference
The SNSC terms of reference set out the objectives and work program for each symptom node as well as member expectations and reporting requirements.
Members of PaCCSC and CST are eligible for membership of any SNSC by self-nomination. Experts may be co-opted or invited to join and SNSCs are encouraged to extend their reach by inviting new members with expertise in a variety of areas, including consumers.